Sukumar Namineni, PhD

Translational life sciences scientist with 10+ years of experience across immunology, stem cell biology, and disease modelling, combining deep experimental expertise with computational analysis. I have recently transitioned toward evaluating emerging biotech technologies and early-stage opportunities, with experience in technology landscape analysis, proof-of-concept development, and technical–commercial assessment. My interests lie at the intersection of biology, engineering, and computation — particularly where advances in biological systems and data-driven approaches can translate into scalable, high-impact ventures. I am particularly interested in identifying technologies that combine strong scientific foundations with clear paths to scalability, defensibility, and real-world impact.Open to conversations around early-stage biotech, deep tech investing, and technology evaluation.